FDA Clearance Tracker · K173441
Neurosoft TMS (also CloudTMS)
Last checked: Nov 19, 2026Latest source record: Dec 13, 2017 (this decision)Source: openFDAMethods & limitations
Decided
Dec 13, 2017
Substantially Equivalent
Time to decision
37 days
Received Nov 6, 2017. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Special
Device class
Class II
The decision
- FDA number
- K173441
- Device name
- Neurosoft TMS (also CloudTMS)
- Applicant
- Teleemg, LLC
- Applicant location
- Woburn, MA
- Received
- Nov 6, 2017
- Decided
- Dec 13, 2017
- Decision
- Substantially Equivalent
- Submission type
- Special
Device type
- Device type
- Transcranial Magnetic Stimulator (OBP)
- Device class
- Class II
- Regulation
- 21 CFR 882.5805
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code OBP. The earliest in FDA's data is DEN070003, decided Oct 7, 2008.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K173441
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Teleemg, LLC
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- CloudTMS Edge510(k)
K250689 · Decided Sep 14, 2025 · 192 days after receipt
Device type: Transcranial Magnetic Stimulator (OBP) · Neurology & Neurosurgery
- CloudTMS Edge for OCD510(k)
K233742 · Decided Dec 22, 2023 · 30 days after receipt
Device type: Transcranial Magnetic Stimulation System For Obsessive-Compulsive Disorder (QCI) · Neurology & Neurosurgery
- CloudTMS for OCD510(k)
K221129 · Decided Mar 10, 2023 · 326 days after receipt
Device type: Transcranial Magnetic Stimulation System For Obsessive-Compulsive Disorder (QCI) · Neurology & Neurosurgery
2 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.